{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:25:44Z","timestamp":1768551944606,"version":"3.49.0"},"posted":{"date-parts":[[2021,4,11]]},"group-title":"Infectious Diseases (except HIV\/AIDS)","reference-count":44,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,4,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The United States (US) Expanded Access Program (EAP) to COVID-19 convalescent plasma was initiated in response to the rapid spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease-2019 (COVID-19). While randomized clinical trials were in various stages of development and enrollment, there was an urgent need for widespread access to potential therapeutic agents particularly for vulnerable racial and ethnic minority populations who were disproportionately affected by the pandemic. The objective of this study is to report on the demographic, geographic, and chronological access to COVID-19 convalescent plasma in the US via the EAP.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods and findings<\/jats:title>\n                  <jats:p>Mayo Clinic served as the central IRB for all participating facilities and any US physician could participate as local physician\u2013principal investigator. Registration occurred through the EAP central website. Blood banks rapidly developed logistics to provide convalescent plasma to hospitalized patients with COVID-19. Demographic and clinical characteristics of all enrolled patients in the EAP were summarized. Temporal trends in access to COVID-19 convalescent plasma were investigated by comparing daily and weekly changes in EAP enrollment in response to changes in infection rate on a state level. Geographical analyses on access to convalescent plasma included assessing EAP enrollment in all national hospital referral regions as well as assessing enrollment in metropolitan and less populated areas which did not have access to COVID-19 clinical trials.<\/jats:p>\n                  <jats:p>From April 3 to August 23, 2020, 105,717 hospitalized patients with severe or life-threatening COVID-19 were enrolled in the EAP. A majority of patients were older than 60 years of age (57.8%), male (58.4%), and overweight or obese (83.8%). There was substantial inclusion of minorities and underserved populations, including 46.4% of patients with a race other than White, and 37.2% of patients were of Hispanic ethnicity. Severe or life-threatening COVID-19 was present in 61.8% of patients and 18.9% of patients were mechanically ventilated at time of convalescent plasma infusion. Chronologically and geographically, increases in enrollment in the EAP closely followed confirmed infections across all 50 states. Nearly all national hospital referral regions enrolled patients in the EAP, including both in metropolitan and less populated areas.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The EAP successfully provided widespread access to COVID-19 convalescent plasma in all 50 states, including for underserved racial and ethnic minority populations. The efficient study design of the EAP may serve as an example framework for future efforts when broad access to a treatment is needed in response to a dynamic disease affecting demographic groups and areas historically underrepresented in clinical studies.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2021.04.08.21255115","type":"posted-content","created":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T05:10:13Z","timestamp":1618117813000},"source":"Crossref","is-referenced-by-count":5,"title":["Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8116-3538","authenticated-orcid":false,"given":"Jonathon W.","family":"Senefeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8365-1375","authenticated-orcid":false,"given":"Patrick W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6850-6823","authenticated-orcid":false,"given":"Katie L.","family":"Kunze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-4754","authenticated-orcid":false,"given":"Noud","family":"van Helmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4560-8728","authenticated-orcid":false,"given":"Stephen A.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6458-0142","authenticated-orcid":false,"given":"Chad C.","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-6059","authenticated-orcid":false,"given":"Katelyn A.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7666-7782","authenticated-orcid":false,"given":"Michael A.","family":"Golafshar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7779-4940","authenticated-orcid":false,"given":"Molly M.","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-0989","authenticated-orcid":false,"given":"Matthew R.","family":"Buras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8852-4666","authenticated-orcid":false,"given":"Allan M.","family":"Klompas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6825-7297","authenticated-orcid":false,"given":"Matthew A.","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-1308","authenticated-orcid":false,"given":"Juan C. Diaz","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9647-7660","authenticated-orcid":false,"given":"Sarah E.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5022-326X","authenticated-orcid":false,"given":"John R.A.","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole C.","family":"Verdun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5619-4404","authenticated-orcid":false,"given":"Peter","family":"Marks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille M.","family":"van Buskirk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8654-3732","authenticated-orcid":false,"given":"Jeffrey L.","family":"Winters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3270-4913","authenticated-orcid":false,"given":"James R.","family":"Stubbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Rea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0214-0651","authenticated-orcid":false,"given":"Vitaly","family":"Herasevich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0410-0549","authenticated-orcid":false,"given":"Emily R.","family":"Whelan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-1805","authenticated-orcid":false,"given":"Andrew J.","family":"Clayburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2565-3318","authenticated-orcid":false,"given":"Kathryn F.","family":"Larson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4908-9774","authenticated-orcid":false,"given":"Juan G.","family":"Ripoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-2871","authenticated-orcid":false,"given":"Kylie J.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0721-8451","authenticated-orcid":false,"given":"Matthew N.P.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1135-9006","authenticated-orcid":false,"given":"Joshua J.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0195-5875","authenticated-orcid":false,"given":"Riley J.","family":"Regimbal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8429-3581","authenticated-orcid":false,"given":"Philippe R.","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2267-1473","authenticated-orcid":false,"given":"Janis E.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel T.","family":"Greenshields","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0151-966X","authenticated-orcid":false,"given":"Nigel S.","family":"Paneth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-1810","authenticated-orcid":false,"given":"DeLisa","family":"Fairweather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0625-0444","authenticated-orcid":false,"given":"R. Scott","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-9167","authenticated-orcid":false,"given":"Arturo","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0818-273X","authenticated-orcid":false,"given":"Rickey E.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7135-7643","authenticated-orcid":false,"given":"Michael J.","family":"Joyner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2021041211100915000_2021.04.08.21255115v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30863-1"},{"key":"2021041211100915000_2021.04.08.21255115v1.2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-3012"},{"key":"2021041211100915000_2021.04.08.21255115v1.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775"},{"key":"2021041211100915000_2021.04.08.21255115v1.4","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3596"},{"key":"2021041211100915000_2021.04.08.21255115v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30304-0"},{"key":"2021041211100915000_2021.04.08.21255115v1.6","doi-asserted-by":"publisher","DOI":"10.1101\/2020.07.29.20162917"},{"key":"2021041211100915000_2021.04.08.21255115v1.7","doi-asserted-by":"crossref","unstructured":"Ripoll Sanz J , van Helmond N , Senefeld JW , Wiggins CC , Klassen SA , Baker SE , et al. Convalescent Plasma for Infectious Diseases: Historical Framework and Use in COVID-19. Clinical Microbiology Newsletter. 2021;ahead of print.","DOI":"10.1016\/j.clinmicnews.2021.02.001"},{"key":"2021041211100915000_2021.04.08.21255115v1.8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e3181d44c1e"},{"key":"2021041211100915000_2021.04.08.21255115v1.9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.8.1695"},{"key":"2021041211100915000_2021.04.08.21255115v1.10","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/21.1.150"},{"key":"2021041211100915000_2021.04.08.21255115v1.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-004-1271-9"},{"key":"2021041211100915000_2021.04.08.21255115v1.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4783"},{"key":"2021041211100915000_2021.04.08.21255115v1.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.10044"},{"key":"2021041211100915000_2021.04.08.21255115v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2020.05.014"},{"key":"2021041211100915000_2021.04.08.21255115v1.15","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1088-9"},{"key":"2021041211100915000_2021.04.08.21255115v1.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2023616"},{"key":"2021041211100915000_2021.04.08.21255115v1.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2019445"},{"key":"2021041211100915000_2021.04.08.21255115v1.18","unstructured":"Joyner MJ . Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19. Rochester, MN, US.2020 [updated 08\/03\/2020; cited 2020 10\/23\/2020]. 1.0:[Available from: https:\/\/www.uscovidplasma.org\/physicians-protocol."},{"key":"2021041211100915000_2021.04.08.21255115v1.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031893"},{"key":"2021041211100915000_2021.04.08.21255115v1.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2020.06.028"},{"key":"2021041211100915000_2021.04.08.21255115v1.21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140200"},{"key":"2021041211100915000_2021.04.08.21255115v1.22","unstructured":"Mayo Clinic . USCovidPlasma. Rochester, MN, US. 2020 [cited 2020 10\/23\/2020]. Available from: https:\/\/www.uscovidplasma.org\/."},{"key":"2021041211100915000_2021.04.08.21255115v1.23","unstructured":"US Food and Drug Administration. Code of Federal Regulations Title 21 - Part 50 Section 50.23. 2019."},{"key":"2021041211100915000_2021.04.08.21255115v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2021041211100915000_2021.04.08.21255115v1.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2021041211100915000_2021.04.08.21255115v1.26","unstructured":"OFFICE OF MANAGEMENT AND BUDGET. Revisions to the Standards for the Classification of Federal Data on Race and Ethnicity. Federal Register; 1997. p. 58782."},{"key":"2021041211100915000_2021.04.08.21255115v1.27","unstructured":"U.S. Census Bureau. Population Estimates 2018. Available from: https:\/\/www2.census.gov\/programs-surveys\/popest\/datasets\/2010-2018\/counties\/asrh\/."},{"key":"2021041211100915000_2021.04.08.21255115v1.28","unstructured":"The New York Times. Coronavirus US Cases New York City: The New York Times Company; 2020. Available from: https:\/\/www.nytimes.com\/interactive\/2020\/us\/coronavirus-us-cases.html."},{"key":"2021041211100915000_2021.04.08.21255115v1.29","unstructured":"Office of Management and Budget. Standards for Delineating Metropolitan and Micropolitan Statistical Areas; Notice Federal Register; 2010. p. 37249\u201352."},{"key":"2021041211100915000_2021.04.08.21255115v1.30","unstructured":"O\u2019Connor SP . United States Regions Washington DC: National Geographic Society 2012 [01\/14\/2021]. Available from: https:\/\/www.nationalgeographic.org\/maps\/united-states-regions\/."},{"key":"2021041211100915000_2021.04.08.21255115v1.31","unstructured":"American Hospital Directory. Hospital Profiles 2020 [01\/14\/2021]. Available from: https:\/\/www.ahd.com\/search.php."},{"key":"2021041211100915000_2021.04.08.21255115v1.32","unstructured":"CMS. Provider of Services Baltimore: Centers for Medicare & Medicaid Services; 2020. Available from: https:\/\/www.cms.gov\/Research-Statistics-Data-and-Systems\/Downloadable-Public-Use-Files\/Provider-of-Services."},{"key":"2021041211100915000_2021.04.08.21255115v1.33","unstructured":"Hilton DM . Letter of authorization Silver Spring: US Food & Drug Administration; 2020 [01\/14\/2021]."},{"key":"2021041211100915000_2021.04.08.21255115v1.34","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6918e1"},{"key":"2021041211100915000_2021.04.08.21255115v1.35","unstructured":"James M. Blum reports personal fees from Clew Medical, outside the submitted work. No other potential conflicts of interest were disclosed."},{"key":"2021041211100915000_2021.04.08.21255115v1.36","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.7202"},{"key":"2021041211100915000_2021.04.08.21255115v1.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMsa2011686"},{"key":"2021041211100915000_2021.04.08.21255115v1.38","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3857"},{"key":"2021041211100915000_2021.04.08.21255115v1.39","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6933e2"},{"key":"2021041211100915000_2021.04.08.21255115v1.40","article-title":"Participation of racial\/ethnic groups in clinical trials and race-related labeling: a review of new molecular entities approved 1995-1999","year":"2001;93(12 ):18-24","journal-title":"J Natl Med Assoc"},{"issue":"4","key":"2021041211100915000_2021.04.08.21255115v1.41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.4155\/cli.14.21","article-title":"Geographic distribution of clinical trials may lead to inequities in access","volume":"4","year":"2014","journal-title":"Clin Invest"},{"key":"2021041211100915000_2021.04.08.21255115v1.42","unstructured":"Administration UFaD. CLINICAL MEMORANDUM - COVID-19 Convalescent Plasma Silver Spring2020. Available from: https:\/\/www.fda.gov\/media\/141480\/download."},{"key":"2021041211100915000_2021.04.08.21255115v1.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"2021041211100915000_2021.04.08.21255115v1.44","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-016-0760-x"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2021.04.08.21255115","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:12:49Z","timestamp":1768486369000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2021.04.08.21255115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,11]]},"references-count":44,"URL":"https:\/\/doi.org\/10.1101\/2021.04.08.21255115","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1371\/journal.pmed.1003872","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2021,4,11]]},"subtype":"preprint"}}